$CLRI
Cleartronic, Inc.

2022 Q4 Form 10-K Financial Statement

#000109181822000187 Filed on December 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022
Revenue $506.7K $489.7K $2.018M
YoY Change -2.41% 12.99% 22.18%
Cost Of Revenue $77.49K $86.06K $334.1K
YoY Change -15.99% 25.23% 25.0%
Gross Profit $429.2K $403.6K $1.683M
YoY Change 0.52% 10.68% 21.63%
Gross Profit Margin 84.71% 82.42% 83.44%
Selling, General & Admin $389.7K $272.6K $1.121M
YoY Change 23.15% 11.9% 13.42%
% of Gross Profit 90.81% 67.54% 66.6%
Research & Development $21.82K $61.72K $204.9K
YoY Change -55.71% 25.83% 22.22%
% of Gross Profit 5.08% 15.29% 12.17%
Depreciation & Amortization $1.080K $1.000K $3.732K
YoY Change 32.68% 40.85% 75.29%
% of Gross Profit 0.25% 0.25% 0.22%
Operating Expenses $412.6K $335.3K $1.330M
YoY Change 12.57% 14.3% 14.8%
Operating Profit $16.54K $68.30K $353.6K
YoY Change -72.63% -4.23% 56.7%
Interest Expense $550.00 -$130.00 -$530.00
YoY Change -423.53% -51.85% -58.59%
% of Operating Profit 3.33% -0.19% -0.15%
Other Income/Expense, Net $549.00 $47.26K
YoY Change -426.79% -65.1%
Pretax Income $17.08K $68.17K $400.9K
YoY Change -71.64% -63.99% 11.02%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $17.08K $57.83K $400.9K
YoY Change -71.64% -69.45% 11.02%
Net Earnings / Revenue 3.37% 11.81% 19.87%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $96.47 $0.00
COMMON SHARES
Basic Shares Outstanding 228.1M shares 228.1M shares 228.2M shares
Diluted Shares Outstanding 599.3M shares 599.6M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $280.2K $468.2K $468.2K
YoY Change -25.9% 16.75% 16.75%
Cash & Equivalents $280.2K $468.2K
Short-Term Investments
Other Short-Term Assets $43.67K $53.61K $53.61K
YoY Change 211.48% 13.15% 13.15%
Inventory $21.10K $21.10K $21.10K
Prepaid Expenses $25.67K $15.36K
Receivables $562.8K $538.0K $538.0K
Other Receivables $670.00 $0.00 $0.00
Total Short-Term Assets $908.4K $1.081M $1.081M
YoY Change 32.27% 38.0% 38.0%
LONG-TERM ASSETS
Property, Plant & Equipment $14.06K $15.14K $15.14K
YoY Change -10.07% 32.93% 32.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $67.36K $68.44K $68.44K
YoY Change 0.81% 21.8% 21.8%
TOTAL ASSETS
Total Short-Term Assets $908.4K $1.081M $1.081M
Total Long-Term Assets $67.36K $68.44K $68.44K
Total Assets $975.7K $1.149M $1.149M
YoY Change 29.48% 36.91% 36.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $108.2K $75.22K $75.22K
YoY Change -41.97% -52.97% -52.97%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $910.5K $1.087M $1.087M
YoY Change -9.08% -4.38% -4.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $99.57K $113.3K $113.3K
YoY Change -30.95% -26.67% -26.67%
Total Long-Term Liabilities $99.57K $113.3K $113.3K
YoY Change -30.95% -26.67% -26.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $910.5K $1.087M $1.087M
Total Long-Term Liabilities $99.57K $113.3K $113.3K
Total Liabilities $1.010M $1.201M $1.201M
YoY Change -11.83% -7.05% -7.05%
SHAREHOLDERS EQUITY
Retained Earnings -$15.28M -$15.29M
YoY Change -2.29% -2.55%
Common Stock $2.288K $2.281K
YoY Change 0.09% -0.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$34.30K -$51.38K -$51.38K
YoY Change
Total Liabilities & Shareholders Equity $975.7K $1.149M $1.149M
YoY Change 29.48% 36.91% 36.91%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022
OPERATING ACTIVITIES
Net Income $17.08K $57.83K $400.9K
YoY Change -71.64% -69.45% 11.02%
Depreciation, Depletion And Amortization $1.080K $1.000K $3.732K
YoY Change 32.68% 40.85% 75.29%
Cash From Operating Activities -$188.0K $243.6K $74.65K
YoY Change 953.36% 138.94% -80.28%
INVESTING ACTIVITIES
Capital Expenditures -$2.420K $7.483K
YoY Change -19.87% 46.93%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.420K -$7.483K
YoY Change -19.87% 46.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -$188.0K 243.6K $74.65K
Cash From Investing Activities -2.420K -$7.483K
Cash From Financing Activities 0.000
Net Change In Cash -$188.0K 241.1K $67.17K
YoY Change 720.77% 143.79% -79.33%
FREE CASH FLOW
Cash From Operating Activities -$188.0K $243.6K $74.65K
Capital Expenditures -$2.420K $7.483K
Free Cash Flow -$188.0K $246.0K $67.17K
YoY Change 720.77% 134.37% -82.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-55329
CY2022 dei Entity Registrant Name
EntityRegistrantName
CLEARTRONIC, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0958798
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
8000 North Federal Highway
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33487
CY2022 dei City Area Code
CityAreaCode
(561)
CY2022 dei Local Phone Number
LocalPhoneNumber
939-3300
CY2022 dei Security12b Title
Security12bTitle
Common stock, par value $0.00001 per share
CY2022 dei Trading Symbol
TradingSymbol
CLRI
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
6843621 usd
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
228120695 shares
CY2022 dei Auditor Firm
AuditorFirmId
287
CY2022 dei Auditor Name
AuditorName
Liggett & Webb, P.A.
CY2022 dei Auditor Location
AuditorLocation
Boynton Beach, Florida
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
468167 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
401001 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
538030 usd
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
320245 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
21097 usd
CY2021Q3 us-gaap Inventory Net
InventoryNet
14653 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
53611 usd
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47383 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1080905 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
783282 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15142 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11391 usd
CY2022Q3 us-gaap Due From Related Parties
DueFromRelatedParties
53302 usd
CY2021Q3 us-gaap Due From Related Parties
DueFromRelatedParties
44801 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
53302 usd
CY2021Q3 us-gaap Other Assets
OtherAssets
44801 usd
CY2022Q3 us-gaap Assets
Assets
1149349 usd
CY2021Q3 us-gaap Assets
Assets
839474 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
75217 usd
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
159952 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1012211 usd
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
977296 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1087428 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1137248 usd
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
113300 usd
CY2021Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
154500 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
113300 usd
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
154500 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1200728 usd
CY2021Q3 us-gaap Liabilities
Liabilities
1291748 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2281 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2286 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240112 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240107 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15293848 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15694743 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51379 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-452274 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1149349 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
839474 usd
CY2022 us-gaap Revenues
Revenues
2017563 usd
CY2021 us-gaap Revenues
Revenues
1651297 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
334138 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
267298 usd
CY2022 us-gaap Gross Profit
GrossProfit
1683425 usd
CY2021 us-gaap Gross Profit
GrossProfit
1383999 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
659796 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
571242 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
461345 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
417286 usd
CY2022 us-gaap Depreciation
Depreciation
3732 usd
CY2021 us-gaap Depreciation
Depreciation
2129 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
204918 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
167661 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1329791 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
1158318 usd
CY2022 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
47792 usd
CY2021 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
29965 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
106727 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-531 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1275 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47261 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
135417 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
400895 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
361098 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
400895 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
361098 usd
CY2022 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
41037 usd
CY2021 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
40927 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
359858 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
320171 usd
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228239979 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
226520440 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599601614 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
597882075 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
400895 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
361098 usd
CY2022 us-gaap Depreciation
Depreciation
3732 usd
CY2021 us-gaap Depreciation
Depreciation
2129 usd
CY2021 clri Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPPPLoan
106727 usd
CY2022 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
47792 usd
CY2021 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
29965 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14000 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
231785 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
111630 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6444 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2182 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6228 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9541 usd
CY2022 clri Increase Decrease In Due From Related Parties Non Current
IncreaseDecreaseInDueFromRelatedPartiesNonCurrent
8501 usd
CY2021 clri Increase Decrease In Due From Related Parties Non Current
IncreaseDecreaseInDueFromRelatedPartiesNonCurrent
31380 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-36943 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-63458 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-43457 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6285 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
403671 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74649 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
378558 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7483 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5093 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7483 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5093 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
48447 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-48447 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
67166 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
325018 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
401001 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
75983 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
468167 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
401001 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
53 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2754 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
690 usd
CY2022 clri Shares Returned
SharesReturned
875000 shares
CY2021 clri Shares Returned
SharesReturned
875000 shares
CY2021 clri Returnof Sharesof Common Stockin Exchangefor Notesand Interest Receivable.
ReturnofSharesofCommonStockinExchangeforNotesandInterestReceivable.
26576 usd
CY2022 clri Shares Of Common Stock
SharesOfCommonStock
458300 shares
CY2021 clri Shares Of Common Stock
SharesOfCommonStock
458300 shares
CY2022 clri Cancellationof Shares Of Common Stock
CancellationofSharesOfCommonStock
5 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-786796 usd
CY2021 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
26576 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
361098 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-452274 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
400895 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51379 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin:0pt; text-align: justify;"><b>USE OF ESTIMATES</b></p><p style="margin:0pt; text-align: justify;"> </p><p style="margin:0pt; text-align: justify;">In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period.</p><p style="margin:0pt; text-align: justify;"> </p><p style="margin:0pt; text-align: justify;">Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results. </p><p style="margin:0pt; text-align: justify;"> </p><p style="margin:0pt; text-align: justify;">Significant estimates include the assumptions used in valuation of deferred tax assets, estimated useful life of property and equipment, valuation of inventory and allowance for doubtful accounts.</p><p style="margin:0pt; text-align: justify;"> </p>
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228239979 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
226520440 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
359858 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
320171 usd
CY2022 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
41073 usd
CY2021 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
40929 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18000 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000 usd
CY2022Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
38250 usd
CY2021Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
41283 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15361 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6100 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin:0pt; text-align: justify;"><b>CONCENTRATION OF CREDIT RISK </b></p><p style="margin:0pt; text-align: justify;"> </p><p style="margin:0pt; text-align: justify;">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in non interest-bearing transaction accounts are insured up to a maximum of $250,000 at all FDIC-insured institutions. As of September 30, 2022 and September 30, 2021, the Company had $208,135 and $139,577, respectively, in excess of FDIC insurance limits.</p><p style="margin:0pt; text-align: justify;"> </p>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2021Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022 clri Amount Of Fdic Insurance Limits
AmountOfFdicInsuranceLimits
208135 usd
CY2021 clri Amount Of Fdic Insurance Limits
AmountOfFdicInsuranceLimits
139577 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
204918 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
167661 usd
CY2022Q3 us-gaap Deferred Subscriber Acquisition Costs Current
DeferredSubscriberAcquisitionCostsCurrent
38250 usd
CY2021Q3 us-gaap Deferred Subscriber Acquisition Costs Current
DeferredSubscriberAcquisitionCostsCurrent
41283 usd
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
1125511 usd
CY2021Q3 us-gaap Deferred Revenue
DeferredRevenue
1131796 usd
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
400895 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
361098 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228239979 shares
CY2022 us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
2017563 usd
CY2021 us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
1651297 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1131796 usd
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
728120 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1125511 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1131796 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
359858 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
320171 usd
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
226520440 shares
CY2022 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
371361635 shares
CY2021 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
371361635 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599601614 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
597882075 shares
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
21097 usd
CY2022Q3 us-gaap Other Inventory
OtherInventory
0 usd
CY2021Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
12593 usd
CY2021Q3 us-gaap Other Inventory
OtherInventory
2060 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
51318 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
20280 usd
CY2020Q2 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
106727 usd
CY2022Q3 us-gaap Long Term Debt Maturity Date
LongTermDebtMaturityDate
2025-06-10
CY2022Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.01 pure
CY2021Q3 clri Loan Forgiven
LoanForgiven
1 pure
CY2021 clri Cancellationof Shares Of Common Stock
CancellationofSharesOfCommonStock
usd
CY2021 clri Series C Convertible Preferred Shares Exchanged For Common Stock
SeriesCConvertiblePreferredSharesExchangedForCommonStock
usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21605 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14122 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6463 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2731 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15142 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11391 usd
CY2022 us-gaap Depreciation
Depreciation
3732 usd
CY2021 us-gaap Depreciation
Depreciation
2129 usd
CY2022 us-gaap Temporary Equity Description
TemporaryEquityDescription
There are currently 5 series of preferred stock designated as follows:  ● 1,250,000 shares have been designated as Series A Preferred Stock, 512,996 of which are issued and outstanding;   ● 10 shares have been designated as Series B Preferred Stock, none of which is issued and outstanding;   ● 50,000,000 shares have been designated as Series C Preferred Stock, 3,341,503 of which are issued and outstanding; and   ● 10,000,000 shares have been designated Series D Preferred stock, of which 670,904 are issued and outstanding; and  ● 10,000,000 shares have been designated Series E Preferred stock, of which 3,000,000 are issued and outstanding.  
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
1167 usd
CY2020 us-gaap Interest And Other Income
InterestAndOtherIncome
409 usd
CY2021Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0 usd
CY2020Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
48447 usd
CY2019Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
17588 usd
CY2021Q1 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
8002 usd
CY2019 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
65000 usd
CY2021 clri Interest Rate
InterestRate
0.08 pure
CY2019Q3 us-gaap Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid
DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid
3405 usd
CY2021 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
48447 usd
CY2020 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
26832 usd
CY2021 clri Debt Conversion In Promissory Note
DebtConversionInPromissoryNote
0 usd
CY2020 clri Debt Conversion In Promissory Note
DebtConversionInPromissoryNote
48447 usd
CY2021 clri Gain Loss On Forgiveness Of Ppp Loan
GainLossOnForgivenessOfPppLoan
106727 usd
CY2022 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
usd
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3511923 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
26973 usd
CY2021 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
17901 usd
CY2021Q4 clri Area Of Leased Facility
AreaOfLeasedFacility
2000 sqft
CY2021Q4 clri Monthly Rental Cost
MonthlyRentalCost
2200 usd
CY2021Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-11-30
CY2022 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
26973 usd
CY2021 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
17901 usd
CY2022 clri Concentration Risk Percentage
ConcentrationRiskPercentage
0.10 pure
CY2021 clri Concentration Risk Percentage
ConcentrationRiskPercentage
0.10 pure
CY2022 us-gaap Royalty Expense
RoyaltyExpense
8000 usd
CY2021 us-gaap Royalty Expense
RoyaltyExpense
8953 usd
CY2022 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
the Company has an adjusted net operating loss carryforward of approximately $13,782,000 that expire through 2039
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.50 pure
CY2022Q3 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2842 usd
CY2021Q3 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2746 usd
CY2022Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
15880 usd
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
12332 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3493201 usd
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3601402 usd
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3616480 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3511923 usd
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3616480 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
79558 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
71660 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
22049 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
19860 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
850 usd
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-5901 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2100 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1434 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-104557 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-87053 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0435 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0435 pure
CY2022 clri Effective Rate Of Deferred Tax Assetin Dollars Per Share
EffectiveRateOfDeferredTaxAssetinDollarsPerShare
0.2535 pure
CY2021 clri Effective Rate Of Deferred Tax Assetin Dollars Per Share
EffectiveRateOfDeferredTaxAssetinDollarsPerShare
0.2535 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2535 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2535 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
1 pure
CY2022 dei Security Exchange Name
SecurityExchangeName
NONE
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228120695 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228578995 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228578995 shares
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 clri Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPPPLoan
usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 clri Returnof Sharesof Common Stockin Exchangefor Notesand Interest Receivable.
ReturnofSharesofCommonStockinExchangeforNotesandInterestReceivable.
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001362516
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false

Files In Submission

Name View Source Status
0001091818-22-000187-index-headers.html Edgar Link pending
0001091818-22-000187-index.html Edgar Link pending
0001091818-22-000187.txt Edgar Link pending
0001091818-22-000187-xbrl.zip Edgar Link pending
clri-20220930.htm.htm Edgar Link pending
clri-20220930.xsd Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
clri-20220930_lab.xml Edgar Link unprocessable
clri-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clri-20220930_def.xml Edgar Link unprocessable
clri-20220930_pre.xml Edgar Link unprocessable
clri-20220930.htm_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending